Clinical Trial

NextGen - Clinical Implication of Next Generation Sequencing

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to traditional culture, these techniques have more sensitivity and could potentially be of a great help in patients with Colony Count of less than 10,000 and more than zero.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2022-01-11; most recent amendment 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2022-05-26
Trial Details
NCT Number NCT05206500
Lead Sponsor Wake Forest University Health Sciences
Conditions Urinary Tract Infections
Enrollment 100 participants
Start Date 2022-05-17
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-08